CA2209892C - Methods and pharmaceutical compositions employing desmethylselegiline - Google Patents

Methods and pharmaceutical compositions employing desmethylselegiline Download PDF

Info

Publication number: CA2209892C
Authority: CA; Canada
Prior art keywords: desmethylselegiline; selegiline; dms; acid addition; pharmaceutically
Prior art date: 1995-01-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA002209892A

Other languages

English (en)

French (fr)

Other versions

CA2209892A1 (en

Inventor

Cheryl D. Blume

Anthony R. Disanto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Somerset Pharmaceuticals Inc

Original Assignee

Somerset Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-13

Filing date

1996-01-11

Publication date

2002-03-05

1996-01-11 Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc

1996-01-11 Priority claimed from PCT/US1996/001561 external-priority patent/WO1996022068A2/en

1996-07-25 Publication of CA2209892A1 publication Critical patent/CA2209892A1/en

2002-03-05 Application granted granted Critical

2002-03-05 Publication of CA2209892C publication Critical patent/CA2209892C/en

2016-01-11 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

Health & Medical Sciences (AREA)
Emergency Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CA002209892A 1995-01-13 1996-01-11 Methods and pharmaceutical compositions employing desmethylselegiline Expired - Fee Related CA2209892C (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US37213995A	1995-01-13	1995-01-13
US08/372,139		1995-01-13
US197995P	1995-07-31	1995-07-31
US60/001,979		1995-07-31
PCT/US1996/001561 WO1996022068A2 (en)	1995-01-13	1996-01-11	Methods and pharmaceutical compositions employing desmethylselegiline

Publications (2)

Publication Number	Publication Date
CA2209892A1 CA2209892A1 (en)	1996-07-25
CA2209892C true CA2209892C (en)	2002-03-05

Family

ID=26669751

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002209892A Expired - Fee Related CA2209892C (en)	1995-01-13	1996-01-11	Methods and pharmaceutical compositions employing desmethylselegiline

Country Status (5)

Country	Link
EP (1)	EP0812188A2 (fi)
CA (1)	CA2209892C (fi)
FI (1)	FI972988A (fi)
HK (1)	HK1009099A1 (fi)
NO (1)	NO321830B1 (fi)

1996
- 1996-01-11 CA CA002209892A patent/CA2209892C/en not_active Expired - Fee Related
- 1996-01-11 EP EP96904573A patent/EP0812188A2/en not_active Withdrawn
1997
- 1997-07-14 FI FI972988A patent/FI972988A/fi not_active Application Discontinuation
- 1997-07-14 NO NO19973261A patent/NO321830B1/no not_active IP Right Cessation
1998
- 1998-08-24 HK HK98110118A patent/HK1009099A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2209892A1 (en)	1996-07-25
HK1009099A1 (en)	1999-09-10
FI972988A (fi)	1997-09-11
EP0812188A2 (en)	1997-12-17
AU4864496A (en)	1996-08-07
NO321830B1 (no)	2006-07-10
FI972988A0 (fi)	1997-07-14
NO973261L (no)	1997-09-12
NO973261D0 (no)	1997-07-14
AU695359B2 (en)	1998-08-13

Similar Documents

Publication	Publication Date	Title
US6419948B2 (en)	2002-07-16	R(-)desmethylselegiline and its use in transdermal delivery compositions
US6033682A (en)	2000-03-07	S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
Mishira et al.	1979	Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: effects of nisoxetine versus fluoxetine
WO1996022068A2 (en)	1996-07-25	Methods and pharmaceutical compositions employing desmethylselegiline
AU3265293A (en)	1993-07-28	Pharmaceutical composition and process for the preparation thereof
US6299901B1 (en)	2001-10-09	Methods and pharmaceutical compositions employing desmethylselegiline
IE843149L (en)	1985-06-20	Synergistic pharmaceutical compositions
US6319954B1 (en)	2001-11-20	S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
CA2209892C (en)	2002-03-05	Methods and pharmaceutical compositions employing desmethylselegiline
AU695359C (en)	1999-08-19	Methods and pharmaceutical compositions employing desmethylselegiline
AU719447B2 (en)	2000-05-11	Methods and pharmaceutical compositions employing desmethylselegiline
US8530525B2 (en)	2013-09-10	Methods and compositions for protecting and treating neuroinjury
AU9736301A (en)	2002-02-14	Methods and pharmaceutical compositions employing desmethylselegiline enantiomers
CA2420993A1 (en)	2002-03-14	Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions

Legal Events

Date	Code	Title	Description
1997-07-03	EEER	Examination request
2011-01-11	MKLA	Lapsed